BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, February 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 5, 2019
View Archived Issues
ALS exomes identify new culprit
Read More
Organ-specific tumor microenvironment affects response to immunotherapy
Read More
Advaxis submits IND application with the FDA for ADXS-504
Read More
Cerevance initiates phase II study of CVN-424 in Parkinson's disease
Read More
FDA clears IND application for ICTCAR-014
Read More
First patient dosed in phase II study of zilucoplan for the treatment of IMNM
Read More
Kancera presents data from in-depth analysis of KAN-D567 phase Ib program
Read More
Interim data presented from first-in-human study of AMG-596
Read More
Phase I data presented for the oncolytic virus DNX-2401 as treatment of DIPG
Read More
First-in-human data for NTM-1634 botulinum vaccine
Read More
E-Scape Bio describes new LRRK2 inhibitors
Read More
Bristol-Myers Squibb synthesizes new RORC inverse agonists
Read More
Methyltransferase-like protein 11A inhibitors identified at Purdue Research Foundation
Read More
GTx, University of Tennessee patent selective androgen receptor degraders
Read More
Incyte discloses adenosine A2A and/or A2B receptor antagonists
Read More
Immunogenomic responder phenotype for anti-LAG-3 and anti-PD-1 combination therapy
Read More
Development of preclinical canine models for pharmacological studies of AF
Read More
FDA approves IND for first-in-human study of ATRC-101 in solid tumors
Read More
Evgen enters MoU with University of Dundee to advance SFX-01 towards trial for NASH
Read More
Phase I data on SPR-720 support advancement to phase II for NTM pulmonary disease
Read More
Arecor reports phase I topline data for ultrarapid-acting insulin product candidate AT-247
Read More
Aurinia reports data from pivotal study of voclosporin in lupus nephritis
Read More
CARB-X grant supports Vedanta's VE-707 program to prevent multidrug-resistant infections
Read More
Theravance begins phase II allergen challenge study with TD-8236
Read More
NMDA receptor modulator NYX-458 begins phase II for MCI associated with Parkinson's disease
Read More
